Mengis Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $326K | Sell |
|
|||||
|
2023
Q1 | $314K | Sell |
|
|||||
|
2022
Q4 | $368K | Sell |
|
|||||
|
2022
Q3 | $395K | Sell |
|
|||||
|
2022
Q2 | $573K | Sell |
|
|||||
|
2022
Q1 | $705K | Buy |
|
|||||
|
2021
Q4 | $634K | Buy |
|
|||||
|
2021
Q3 | $235K | Buy |
|
|||||
|
2021
Q2 | $246K | Hold |
|
|||||
|
2021
Q1 | $246K | Hold |
|
|||||
|
2020
Q4 | $256K | Hold |
|
|||||
|
2020
Q3 | $202K | Buy |
|